948 related articles for article (PubMed ID: 29045505)
21. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
22. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
Massoumi RL; Hines OJ; Eibl G; King JC
Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsies in pancreatic cancer.
Kamyabi N; Bernard V; Maitra A
Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
[No Abstract] [Full Text] [Related]
24. Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.
Groot VP; Mosier S; Javed AA; Teinor JA; Gemenetzis G; Ding D; Haley LM; Yu J; Burkhart RA; Hasanain A; Debeljak M; Kamiyama H; Narang A; Laheru DA; Zheng L; Lin MT; Gocke CD; Fishman EK; Hruban RH; Goggins MG; Molenaar IQ; Cameron JL; Weiss MJ; Velculescu VE; He J; Wolfgang CL; Eshleman JR
Clin Cancer Res; 2019 Aug; 25(16):4973-4984. PubMed ID: 31142500
[TBL] [Abstract][Full Text] [Related]
25. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
27. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
[TBL] [Abstract][Full Text] [Related]
28. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
29. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.
Capello M; Vykoukal JV; Katayama H; Bantis LE; Wang H; Kundnani DL; Aguilar-Bonavides C; Aguilar M; Tripathi SC; Dhillon DS; Momin AA; Peters H; Katz MH; Alvarez H; Bernard V; Ferri-Borgogno S; Brand R; Adler DG; Firpo MA; Mulvihill SJ; Molldrem JJ; Feng Z; Taguchi A; Maitra A; Hanash SM
Nat Commun; 2019 Jan; 10(1):254. PubMed ID: 30651550
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis.
Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X
J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461
[TBL] [Abstract][Full Text] [Related]
31. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
32. Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.
Ko J; Bhagwat N; Yee SS; Ortiz N; Sahmoud A; Black T; Aiello NM; McKenzie L; O'Hara M; Redlinger C; Romeo J; Carpenter EL; Stanger BZ; Issadore D
ACS Nano; 2017 Nov; 11(11):11182-11193. PubMed ID: 29019651
[TBL] [Abstract][Full Text] [Related]
33. Next-Generation Sequencing in Pancreatic Cancer.
Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
[TBL] [Abstract][Full Text] [Related]
34. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
Goto T; Fujiya M; Konishi H; Sasajima J; Fujibayashi S; Hayashi A; Utsumi T; Sato H; Iwama T; Ijiri M; Sakatani A; Tanaka K; Nomura Y; Ueno N; Kashima S; Moriichi K; Mizukami Y; Kohgo Y; Okumura T
BMC Cancer; 2018 Jan; 18(1):116. PubMed ID: 29385987
[TBL] [Abstract][Full Text] [Related]
35. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
Lux A; Kahlert C; Grützmann R; Pilarsky C
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Implications of Multiplex Detection of
Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
[TBL] [Abstract][Full Text] [Related]
37. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
38. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
Mellby LD; Nyberg AP; Johansen JS; Wingren C; Nordestgaard BG; Bojesen SE; Mitchell BL; Sheppard BC; Sears RC; Borrebaeck CAK
J Clin Oncol; 2018 Oct; 36(28):2887-2894. PubMed ID: 30106639
[TBL] [Abstract][Full Text] [Related]
39. Exosomal proteins as potential markers of tumor diagnosis.
Li A; Zhang T; Zheng M; Liu Y; Chen Z
J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
[TBL] [Abstract][Full Text] [Related]
40. Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma.
Terasawa H; Kinugasa H; Ako S; Hirai M; Matsushita H; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Kato H; Nouso K; Okada H
Cancer Biol Ther; 2019; 20(10):1348-1353. PubMed ID: 31328611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
